NIAID Banner Logo Image

HBV Citations List: July, 2021

Literature Citations

1. Anti-HBV Therapeutic Potential of Small Molecule 3,5,6,7,3',4'-Hexamethoxyflavone in Vitro and in Vivo. Tan, M., F. Ren, and X. Yang. Virology, 2021. 560: p. 66-75. PMID[34051476].
[PubMed]. HBV_07_2021.

2. Significant in-vitro and in-vivo Inhibition of HBsAG and HBV pgRNA with ASC42, a Novel Non-steroidal FXR Agonist. Wu, J.Z., X.D. Li, H.D. He, and Q. Zhou. Journal of Hepatology, 2021. 75: p. S703-S704. ISI[000667753802012].
[WOS]. HBV_07_2021.

Patent Citations

This month, no relevant HBV patents were identified.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2024